Background illustration for clinical trials search

Pulmonary Hypertension Clinical Trials

Browse 652 pulmonary hypertension clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

A Study to See if Lepodisiran Can Reduce Plaque in Coronary Arteries of Adults With Elevated Lp(a) Who Have Had Heart Events or Are at High Risk

for
Atherosclerosis, Cardiovascular Diseases, Lipoprotein(a)
Location: York PA, Falls Church VA, Fort Lauderdale FL,
Sponsor: Eli Lilly and Company

Sex: All

Age: 45 - 70+

Code: NCT07613294

Phase 3, Recruiting

Examining the Use of Three Dimensional Ultrasound in the Assessment of Vascular Pathologies

for
PAD - Peripheral Arterial Disease, Vascular Diseases, Wounds
Location: Lake Success NY
Sponsor: Northwell Health

Sex: All

Age: 18+

Code: NCT05134311

Recruiting

PKP2-ACM Natural History Study

for
Cardiomyopathies, Heart Diseases, Cardiovascular Diseases,
Location: Boston MA, Durham NC
Sponsor: Rocket Pharmaceuticals Inc.

Sex: All

Age: 12+

Code: NCT06644742

Recruiting

Equol and Vascular Function in Women With Chronic Kidney Disease

for
Chronic Kidney Disease (Stage 3-4), Vascular Function,
Location: Aurora CO
Sponsor: University of Colorado, Denver

Sex: Female

Age: 50+

Code: NCT07194590

Phase 2, Recruiting

Feasibility of The Health Integrated Nutrition and Kidney Wellness Program

for
Chronic Kidney Disease, Cardiovascular Disease
Location: Pittsburgh PA
Sponsor: University of Pittsburgh

Sex: All

Age: 18+

Code: NCT07518719

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

An Open-label Extension Safety and Efficacy Study of QCZ484 in Hypertensive Patients.

for
Hypertension (HTN)
Location: Berlin NJ, Linwood PA, Baltimore MD, Lanham MD,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07543120

Phase 2, Recruiting

A Safety and Tolerability Trial Evaluating CTX310 in Participants With Refractory Dyslipidemias

for
Cardiovascular, Metabolic Disease, Dyslipidemias,
Location: Rochester NY, Durham NC, Hialeah FL, High Point NC,
Sponsor: CRISPR Therapeutics AG

Sex: All

Age: 18 - 70+

Code: NCT07491172

Phase 1, Recruiting

NightWare and Cardiovascular Health in Veterans With PTSD

for
Post-traumatic Stress Disorder (PTSD), Cardiovascular Diseases,
Location: Aurora CO
Sponsor: VA Office of Research and Development

Sex: All

Age: 22 - 70+

Code: NCT06419959

Recruiting

Strong Teens for Healthy Schools Change Club: A Civic Engagement Approach to Improving Physical Activity and Healthy Eating Environments

for
Cardiovascular Diseases, Nutrition, Physical Activity
Location: Dallas TX
Sponsor: Texas A&M University

Sex: All

Age: 8+

Code: NCT05867433

Recruiting

FES Cycling With BFR in the Spinal Cord Injury Population

for
Spinal Cord Injury, Cardio Vascular Disease,
Location: Toronto
Sponsor: Dr. B. Catharine. Craven

Sex: All

Age: 18 - 70+

Code: NCT07588503

Phase 1, Recruiting

A Study to Evaluate ALN-AGT01 RVR in Adult Patients With Mild to Moderate Hypertension Pretreated With Zilebesiran

for
Hypertension
Location: Lake Forest CA
Sponsor: Alnylam Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT07553442

Phase 2, Recruiting

Investigating the Combined Effects of Protein, Blueberries, and Exercise on Cardiovascular Health and Frailty in Older Nova Scotians

for
Cardiovascular Disease, Frailty
Location: Halifax
Sponsor: Nova Scotia Health Authority

Sex: All

Age: 65+

Code: NCT06693271

Recruiting

GRAfT 2.0. A Multimodal Prospective Approach to Define the Mechanisms and Clinical Features of Acute and Chronic Rejection in Lung Transplantation

for
Lung Transplant, End Stage Lung Disease, Rejection
Location: Bethesda MD
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Sex: All

Age: 18 - 70+

Code: NCT07516379

Recruiting

Cardiometabolic Disease and Substrate Metabolism

for
Preeclampsia, Gestational Diabetes Mellitus (GDM),
Location: Knoxville TN
Sponsor: University of Tennessee Graduate School of Medicine

Sex: Female

Age: 18 - 45

Code: NCT07565727

Recruiting

The Effects of Brief Periods of Exercise on Blood Pressure

for
Hypertension (HTN), Pre Hypertension
Location: West Hartford CT
Sponsor: University of Hartford

Sex: All

Age: 18 - 55

Code: NCT07453550

Recruiting

Wearable Evaluation of Ambulatory Readings for Blood Pressure

for
Normal Blood Pressure, Controlled Hypertension,
Location: Boston MA
Sponsor: Stephen Juraschek

Sex: All

Age: 18 - 70+

Code: NCT06610448

Recruiting

Innovative Approaches to Hypertension Management in High-Risk Emergency Department Populations

for
Asymptomatic Hypertension
Location: New York NY
Sponsor: Icahn School of Medicine at Mount Sinai

Sex: All

Age: 18+

Code: NCT07539597

Recruiting

Olpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction - Coronary Computed Tomography Angiography Trial

for
Cardiovascular Disease
Location: Bridgeport CT, Philadelphia PA, Bowie MD, Vaughan,
Sponsor: Amgen

Sex: All

Age: 35 - 70+

Code: NCT07293260

Phase 3, Recruiting

Cardiovascular Function and Response to Stimulation Within the First Year After Spinal Cord Injury

for
Spinal Cord Injuries (SCI),
Location: West Orange NJ
Sponsor: Kessler Foundation

Sex: All

Age: 18 - 70+

Code: NCT06841198

Recruiting

Insomnia Treatment and Cardiometabolic Health in Older Adults With Posttraumatic Stress Disorder

for
Posttraumatic Stress Disorder, Insomnia,
Location: North Hills CA
Sponsor: University of California, Los Angeles

Sex: All

Age: 50+

Code: NCT05516277

Recruiting

What is pulmonary hypertension?

Pulmonary hypertension is raised blood pressure in the arteries that carry blood from the heart to the lungs. Over time the right side of the heart has to pump harder against that pressure, and it can weaken and fail. Symptoms come on slowly: breathlessness with activity, tiredness, chest pressure, dizziness or fainting, and swelling in the ankles or belly. Because these signs look like asthma, heart disease, or simply being out of shape, the diagnosis is often delayed. It is suspected on an echocardiogram and confirmed by right heart catheterization, which measures the pressure directly.

Doctors sort pulmonary hypertension into five groups by cause, and the group decides the treatment. Group 1 is pulmonary arterial hypertension, or PAH, a rare disease of the small lung arteries themselves, which can be idiopathic, inherited, or linked to conditions such as scleroderma. Group 2, the most common, comes from left sided heart disease; group 3 from lung diseases such as COPD and pulmonary fibrosis; group 4 from old blood clots in the lungs, which surgery can sometimes cure; and group 5 from other or mixed causes. Most PAH medicines are approved only for group 1, which is why most drug trials enroll people with PAH.

Types of pulmonary hypertension clinical trials

Who can participate in pulmonary hypertension clinical trials?

Groups and functional class, and why they matter for trials

How to enroll in a pulmonary hypertension clinical trial